-
-
-
-
-
-
-
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
-
-
-
-
-
-
-
Moderna (MRNA) Tops Q4 EPS by 51c, Beats on Revenue
-
-
-
-
-
-
-
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Moderna (MRNA) Tops Q3 EPS by $1.54
-
-
-
-
-
-
-
Moderna earnings preview Q2: set for weak qtr amid softer vaccine sales, regulatory headwinds
-
-
-
-
-
-
-
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
-
-
-
-
-
-
-
Argus downgrades Moderna to hold on weak near-term outlook
-
1,227,477 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

